Victrex Regulatory News (VCT)

8 Dec 2009 07:00



8 December 2009

Victrex plc

Board and management changes

Tim Walker has informed the Company of his intention to retire as an executive Director of Victrex plc at the conclusion of the Company's Annual General Meeting on 9 February 2010. He will remain an employee of the Company until 31 March 2010, when he will have reached the normal retirement age of 62. 

Anita Frew, Chairman of Victrex plc, said:

"Tim has been the Group's Production and Technical Director for over ten years and has made an invaluable contribution to Victrex during a period of significant development and investment. On behalf of the Board I wish Tim well in his retirement. We do not propose to appoint a successor at Victrex plc Board level, under the new divisional structure."

Further to the satisfactory completion of the strategic reorganisation and divisionalisation, the Group's Chief Executive, David Hummel, who has managed the VPS division in the short term to oversee the reorganisation, will now focus, as planned, full time on his Group responsibilities. Accordingly, the Company is pleased to announce the appointment of Tim Cooper as Managing Director of the VPS division with effect from 1 January 2010. Tim is currently Group Managing Director of Umeco Composites Process Materials, part of Umeco plc, a leading international provider of supply chain services and advanced composite materials. With his wealth of experience Tim is well placed to lead the strategic development of all aspects of the division.

Enquiries

Victrex plc is an innovative, world leader in high performance materials through the manufacture of VICTREX® PEEK™ polymer, a high performance, easy to process thermoplastic.

With over 30 years experience, Victrex is a global manufacturer of innovative, high performance thermoplastic polymers. We work with customers and end users to deliver technology driven solutions to the challenges and opportunities they face. Our Victrex Polymer Solutions division ('VPS') focuses on developing applications in our transport, industrial and electronics markets and our Invibio Biomaterial Solutions division ('Invibio') focuses on providing specialist solutions for medical device manufacturers.